Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus.
about
Management of refractory status epilepticus in adults: still more questions than answersSeizures - just the tip of the iceberg: Critical care management of super-refractory status epilepticusDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersDrug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteinsGeneralised convulsive status epilepticus: an overviewDrug transporters in the epileptic brain.A novel positron emission tomography imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood-brain barrierABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.Mechanisms of drug resistance in status epilepticus.Drug interactions at the blood-brain barrier: fact or fantasy?Nanotechnology for delivery of drugs to the brain for epilepsy.Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.Status epilepticus: an update.The possible use of the L-type calcium channel antagonist verapamil in drug-resistant epilepsy.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain.Targeting anti-epileptic drug therapy without collateral damage: nanocarrier-based drug delivery.Cluster headache and intracranial aneurysm.A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil.Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB).P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.Epileptic seizure-induced hypertension and its prevention by calcium channel blockers: a real-time study in conscious telemetered rats.Add-on treatment with verapamil in pharmacoresistant canine epilepsy.The Prokinetic, Laxative, and Antidiarrheal Effects of Morus nigra: Possible Muscarinic, Ca(2+) Channel Blocking, and Antimuscarinic Mechanisms.Role of P-glycoprotein inhibitors in children with drug-resistant epilepsy.Multidrug resistance proteins expression in glioma patients with epilepsy.Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression
P2860
Q27028089-2D9FFB91-F957-40C7-9136-5AE00B8A80C8Q28074293-3881D504-BA47-4576-9082-CF9E8A2026BAQ33875271-2ED1AE9B-D217-4CFC-BFB0-80B29827CBF0Q35094603-A451AF82-DA1A-4546-8CDE-29571955A1E0Q36651076-7F3D581F-05B2-474A-8136-BEC1713748FAQ36742736-F4EEC3FD-6419-4B29-847C-F3D2DB690E7AQ36955931-3F5C795E-2579-442F-A21F-3AFC5F42A962Q36957955-AC0FD437-4394-4B17-88E2-6AED8533B9C0Q37106028-818F417B-2D38-4A91-B291-EDD5CC21217FQ37362486-15A109AC-9046-4868-96C4-BE3112E173B7Q37426991-D171F6C9-7B69-4EA0-9D31-D93E6CB54A49Q37806763-5B72E9CA-7975-43BD-AE8A-F204FAC7E909Q37873936-B5E3C48B-DDD0-46CC-9518-E73FE8A1E7AAQ38008973-0127DA4F-1FD4-4CB0-AAA3-D0776C97A0D3Q38107426-58F529BA-5D76-41E1-BD31-F1A750EC7C24Q38633232-28240824-9BF0-42D9-AA21-FD75AA4B9E55Q38888350-9503435A-E06F-42DF-BEB8-25F32BD4038EQ41139588-F6E661E4-7207-4070-80BD-58173C69CDC5Q41676294-08153AD7-A397-4080-9B17-75F5EBD82C85Q42413674-00100C34-ECE3-4560-BA0A-5B29AAD0AD51Q42585832-11264F72-858E-4585-BC6B-61AEC3FA222FQ42597585-65218EA2-A7FF-473E-84CC-61C6290917F1Q42830808-6E4C868C-414E-4A13-AE50-930506BFBCAAQ43273843-9D1663C1-3E79-4D23-AC04-27C79C685A6DQ44982064-89F2B551-3387-416F-80AF-E9BDC0A063C5Q46161425-D55D6D0A-FE72-450F-A134-F491FE490FDBQ46884368-8AAB9425-35FF-4998-9E69-1B67F0846B9EQ47340679-AEB6E485-D14E-4134-B16F-EBA6D684278FQ48560275-4C9AC07B-7AA7-4FEE-8956-C0CA38CDEAA4Q58698331-C7B09E7C-2F69-4CE0-9050-E37D55B6DDB1
P2860
Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Calcium-channel blocker verapa ...... refractory status epilepticus.
@en
Calcium-channel blocker verapa ...... refractory status epilepticus.
@nl
type
label
Calcium-channel blocker verapa ...... refractory status epilepticus.
@en
Calcium-channel blocker verapa ...... refractory status epilepticus.
@nl
prefLabel
Calcium-channel blocker verapa ...... refractory status epilepticus.
@en
Calcium-channel blocker verapa ...... refractory status epilepticus.
@nl
P2093
P2860
P1433
P1476
Calcium-channel blocker verapa ...... refractory status epilepticus.
@en
P2093
Alberto Spalice
Paola Iannetti
Pasquale Parisi
P2860
P304
P356
10.1111/J.1528-1167.2005.59204.X
P577
2005-06-01T00:00:00Z